secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revium Rx. (RVRC)
CIK:        0001839140
Form:       8-K
Filed at:   2026-06-01T13:58:55+00:00
Accession:  0001213900-26-063235
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Revium Rx CFO Arie Gordashnikov resigns; Igor Bluvstein appointed effective May 27, 2026
--------------------------------------------------------------------------------

- Arie Gordashnikov resigned as CFO effective May 27, 2026, with no disagreement with the company.
- Igor Bluvstein appointed CFO same date; previously CFO at Argent BioPharma and G Medical Innovations.
- Bluvstein receives monthly retainer of NIS17,000 plus VAT.
- Bluvstein has over 17 years of financial leadership experience and is a CPA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1839140/000121390026063235/0001213900-26-063235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1839140/000121390026063235/ea0292932-8k_revium.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-063235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer